Author(s): Camus P, Martin WJ nd, Rosenow EC rd
Abstract Share this page
Abstract The amount of literature on amiodarone pulmonary toxicity (APT) peaked in 1983-1984 with several hundred cases reported cumulatively, and declined thereafter. Since the mid-1990s, publications have increased, which suggests that APT remains a current problem in clinical practice. Amiodarone remains difficult to diagnose noninvasively, and although the outcome is good in the majority of patients, not all cases of APT can be controlled satisfactorily.
This article was published in Clin Chest Med
and referenced in Journal of Microbial & Biochemical Technology